Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Ost

Showing results (81-90 of 334) with videos related to

Pageof 34
Sort By:
Biomed Research International|March 21, 2015
The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot studyFilip Poelaert, Charles Van Praet, Anne-Sophie Beerens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et alPiet Ost, Dries Reynders, Karel Decaestecker, et al.
European Urology|November 21, 2018
The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate CancerJoe M O'Sullivan, Daniel Heinrich, Nicholas D James, et al.
Journal of Translational Medicine|February 1, 2017
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic responseKatrien De Wolf, Vibeke Kruse, Nora Sundahl, et al.
International Journal of Oncology|January 18, 2014
Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patientsHoussein El-Saghire, Charlot Vandevoorde, Piet Ost, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 26, 2014
Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complicationsCharles Van Praet, Karel Decaestecker, Valérie Fonteyne, et al.
Seminars in Oncology Nursing|March 16, 2023
Experiences of Men With Prostate Cancer Participating in a Clinical Pathway With a Supervised Group-based Exercise Program to Combat Androgen Deprivation-Induced Side Effects: A Qualitative Focus Group StudyRenée Bultijnck, Elke Rammant, Anneleen Raes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2013
Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapyCharles Van Praet, Piet Ost, Nicolaas Lumen, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2011
Delineation of the postprostatectomy prostate bed using computed tomography: interobserver variability following the EORTC delineation guidelinesPiet Ost, Gert De Meerleer, Tom Vercauteren, et al.
European Urology|September 22, 2014
Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literaturePiet Ost, Alberto Bossi, Karel Decaestecker, et al.
Pageof 34

Showing results (81-90 of 334) with videos related to

Sort By:
Pageof 34
Biomed Research International|March 21, 2015
The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot studyFilip Poelaert, Charles Van Praet, Anne-Sophie Beerens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et alPiet Ost, Dries Reynders, Karel Decaestecker, et al.
European Urology|November 21, 2018
The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate CancerJoe M O'Sullivan, Daniel Heinrich, Nicholas D James, et al.
Journal of Translational Medicine|February 1, 2017
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic responseKatrien De Wolf, Vibeke Kruse, Nora Sundahl, et al.
International Journal of Oncology|January 18, 2014
Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patientsHoussein El-Saghire, Charlot Vandevoorde, Piet Ost, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 26, 2014
Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complicationsCharles Van Praet, Karel Decaestecker, Valérie Fonteyne, et al.
Seminars in Oncology Nursing|March 16, 2023
Experiences of Men With Prostate Cancer Participating in a Clinical Pathway With a Supervised Group-based Exercise Program to Combat Androgen Deprivation-Induced Side Effects: A Qualitative Focus Group StudyRenée Bultijnck, Elke Rammant, Anneleen Raes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2013
Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapyCharles Van Praet, Piet Ost, Nicolaas Lumen, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2011
Delineation of the postprostatectomy prostate bed using computed tomography: interobserver variability following the EORTC delineation guidelinesPiet Ost, Gert De Meerleer, Tom Vercauteren, et al.
European Urology|September 22, 2014
Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literaturePiet Ost, Alberto Bossi, Karel Decaestecker, et al.
Pageof 34